Collegium Pharmaceutical, Inc.成立于2002年4月在特拉华州注册成立，随后于2014年7月在弗吉尼亚州重新注册成立。公司使命是打造一家领先的、多元化的专科药公司，致力于改善重症患者的生活。该公司利用研发努力以及与第三方的收购和许可关系，开发了一系列有意义的差异化产品，用于治疗中度至重度疼痛。
董事
名称
职位
Joseph Ciaffoni
Director, President and Chief Executive Officer
Michael T. Heffernan
Chairman
David Hirsch
Director
Garen G. Bohlin
Director
Gino Santini
Director
Gwen Melincoff
Director
John A. Fallon
Director
John G. Freund
Director
Theodore R. Schroeder
Director
股东
名称
职位
Joseph Ciaffoni
Director, President and Chief Executive Officer
Paul Brannelly
Executive Vice President and Chief Financial Officer
Alison B. Fleming
Executive Vice President and Chief Technology Officer
Scott Dreyer
Executive Vice President and Chief Commercial Officer